Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Genetic Testing topic
No spam. Unsubscribe anytime.
Committee approves limited Medicaid coverage for whole‑genome sequencing for children with complex illness
Summary
The committee approved House Bill 15‑76, which would require the Oklahoma Health Care Authority to pay for whole‑genome sequencing for a narrowly defined set of pediatric patients; proponents said it could expedite diagnoses for roughly 50 children annually and estimated testing costs based on other states' data.
The Oklahoma House Public Health Committee voted to advance House Bill 15‑76, which would require the Oklahoma Health Care Authority to pay for whole‑genome sequencing for a narrowly defined group of patients, largely children with complex or acute illnesses of unknown cause.
Representative Lawson, the bill sponsor, told the committee the measure targets “50 children in the state who have a serious medical condition” and said the test could “expedite a diagnosis.” She said the bill restricts eligibility to patients who meet clinical criteria listed in the bill, such as organ malformations or abnormal laboratory results that suggest a genetic disorder, and includes HIPAA protections and consent requirements for using sequencing data in research.
Committee members asked about cost. Lawson estimated a per‑test charge between $4,500 and $6,500 based on other states and said “the high end $6,500 times 50 kids is $32,500 for the state of Oklahoma in 1 year,” calculating the approximate total. She and other members described the bill as targeting rare, severe cases and said existing stepwise testing can be more costly and time‑consuming than a single whole‑genome test.
After questions the committee adopted the bill by recorded vote; staff reported the tally as five yeas, zero nays, and the committee chair declared the bill passed.
